> too many shortcuts taken in CLIA labs and the LDT space. jesus fuck, this is NOT what I need to hear as we push our salvage therapy companion biomarker into

> too many shortcuts taken in CLIA labs and the LDT space. jesus fuck, this is NOT what I need to hear as we push our salvage therapy companion biomarker into a 160 patient trial. then again I work in pediatrics these days and nobody ever made any money in peds. So I guess there's that. People expect their 99-year-old grandpa to die of prostate cancer (or apnea, or constipation, or...). It's rather a more unpleasant shock when your 3-year-old does the dying. Won't make anyone rich but maybe it'll relieve a little suffering in the world. I guess I'd best be OK with that.